TNNI3 and COVID-19: In a study of 2,736 COVID-19 patients in New York, the overall mortality rate was 18.5%, and even a slight increase in hs cTnI (0.03–0.09 ng/ml) was associated with a higher risk of death (HR 1.75, 95% CI 1.37–2.24) (7).